Advertisement
New Zealand markets close in 4 hours 59 minutes
  • NZX 50

    11,618.52
    -60.16 (-0.52%)
     
  • NZD/USD

    0.6114
    -0.0003 (-0.05%)
     
  • NZD/EUR

    0.5658
    +0.0003 (+0.05%)
     
  • ALL ORDS

    7,935.70
    -99.20 (-1.23%)
     
  • ASX 200

    7,665.60
    -101.10 (-1.30%)
     
  • OIL

    79.24
    +0.01 (+0.01%)
     
  • GOLD

    2,337.30
    -3.90 (-0.17%)
     
  • NASDAQ

    18,736.75
    -132.69 (-0.70%)
     
  • FTSE

    8,183.07
    -71.11 (-0.86%)
     
  • Dow Jones

    38,441.54
    -411.32 (-1.06%)
     
  • DAX

    18,473.29
    -204.58 (-1.10%)
     
  • Hang Seng

    18,477.01
    -344.15 (-1.83%)
     
  • NIKKEI 225

    38,556.87
    -298.50 (-0.77%)
     
  • NZD/JPY

    96.3060
    -0.0390 (-0.04%)
     

Could Pfizer Have an Ozempic Killer on the Way?

Could Pfizer Have an Ozempic Killer on the Way?

It wasn't because so many patients were newly diagnosed with type 2 diabetes. Instead, Ozempic gained widespread popularity for helping people lose weight. A sibling product, Wegovy, a higher-dose version of the active ingredient in Ozempic that is actually approved for weight loss, has flown off pharmacies' shelves as well.